These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16386823)

  • 1. [Calcific arteriolopathy (Calciphylaxis)].
    Duval A; Moranne O; Vanhille P; Hachulla E; Delaporte E
    Rev Med Interne; 2006 Mar; 27(3):184-95. PubMed ID: 16386823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcific uremic arteriolopathy (calciphylaxis): an independent vascular risk factor?].
    Bura-Rivière A
    Rev Med Interne; 2006 Mar; 27(3):181-3. PubMed ID: 16364506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcific uremic arteriolopathy in hemodialysis patient, review of literature through five cases reports].
    Chettati M; Adnouni A; Fadili W; Laouad I
    Nephrol Ther; 2018 Nov; 14(6):439-445. PubMed ID: 30401462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous necrosis from calcific uremic arteriolopathy.
    Coates T; Kirkland GS; Dymock RB; Murphy BF; Brealey JK; Mathew TH; Disney AP
    Am J Kidney Dis; 1998 Sep; 32(3):384-91. PubMed ID: 9740153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciphylaxis in three patients with end-stage renal disease.
    Ivker RA; Woosley J; Briggaman RA
    Arch Dermatol; 1995 Jan; 131(1):63-8. PubMed ID: 7826099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questionable specificity of histologic findings in calcific uremic arteriolopathy.
    Ellis CL; O'Neill WC
    Kidney Int; 2018 Aug; 94(2):390-395. PubMed ID: 29885932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K.
    Riegert-Johnson DL; Kaur JS; Pfeifer EA
    Mayo Clin Proc; 2001 Jul; 76(7):749-52. PubMed ID: 11444409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.
    Colboc H; Moguelet P; Bazin D; Carvalho P; Dillies AS; Chaby G; Maillard H; Kottler D; Goujon E; Jurus C; Panaye M; Frochot V; Letavernier E; Daudon M; Lucas I; Weil R; Courville P; Monfort JB; Chasset F; Senet P;
    JAMA Dermatol; 2019 Jul; 155(7):789-796. PubMed ID: 31116362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
    Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calciphylaxis: a rare differential diagnosis of systemic vasculitis].
    Khellaf M; Wechsler J; Roucayrol AM; Roujeau JC; Godeau B
    Rev Med Interne; 2006 Mar; 27(3):240-3. PubMed ID: 16368166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of calciphylaxis.
    Ong S; Coulson IH
    Skinmed; 2012; 10(3):166-70. PubMed ID: 22779099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calciphylaxis: a rare but potentially fatal event of chronic kidney disease. Case report.
    Marques SA; Kakuda AC; Mendaçolli TJ; Abbade LP; Marques ME
    An Bras Dermatol; 2013; 88(6 Suppl 1):44-7. PubMed ID: 24346877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calciphylaxis of the skin as a sequela of terminal kidney failure. Report and discussion of 3 cases].
    Hiss U; Tronnier M; Rob PM; Gutsche HU; Wolff HH
    Hautarzt; 1999 May; 50(5):350-4. PubMed ID: 10412632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcific uraemic arteriolopathy (calciphylaxis): incidence, clinical features and long term outcomes].
    Esteve V; Almirall J; Luelmo J; Sáez A; Andreu X; García M
    Nefrologia; 2007; 27(5):599-604. PubMed ID: 18045036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calciphylaxis in terminal renal failure as a rare manifestation of leg ulcers].
    Klode J; Winzer M; Böhmer HJ; Heisterkamp T; Dissemond J
    Vasa; 2005 Aug; 34(3):203-6. PubMed ID: 16184843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.
    Chiriac A; Grosu OM; Terinte C; Perţea M
    J Dermatolog Treat; 2020 Aug; 31(5):545-548. PubMed ID: 31075991
    [No Abstract]   [Full Text] [Related]  

  • 18. Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment.
    Jeong HS; Dominguez AR
    Am J Med Sci; 2016 Feb; 351(2):217-27. PubMed ID: 26897281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis: risk factors, diagnosis, and treatment.
    Nigwekar SU; Kroshinsky D; Nazarian RM; Goverman J; Malhotra R; Jackson VA; Kamdar MM; Steele DJ; Thadhani RI
    Am J Kidney Dis; 2015 Jul; 66(1):133-46. PubMed ID: 25960299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.